Cambrian Bioworks
Bengaluru, India· Est.
Cambrian Bioworks delivers automated, high‑throughput molecular diagnostics platforms to accelerate precision medicine in labs worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Cambrian Bioworks delivers automated, high‑throughput molecular diagnostics platforms to accelerate precision medicine in labs worldwide.
OncologyInfectious DiseaseReproductive HealthTransplant MedicinePharmacogenomicsGenetic Disease Screening
Technology Platform
Automated molecular workflow platforms that integrate DNA/RNA extraction, quantification, and library preparation using synthetic‑biology‑optimized reagents and modular robotics.
Opportunities
Scaling into emerging markets and expanding assay portfolios for NIPT and AMR testing can drive significant revenue growth.
Risk Factors
Regulatory approval delays, supply‑chain constraints for critical reagents, and intense competition from larger diagnostics firms pose key risks.
Competitive Landscape
Cambrian differentiates itself through end‑to‑end automation and synthetic‑biology reagents, competing with major players like Illumina, Thermo Fisher, and Roche.